Answers are grounded in this paper and cite their sources.
Randomized trial evaluates smartphone ACT's feasibility and acceptability in breast cancer survivors, suggesting future research is needed.
Objective: This study examined the feasibility and potential acceptability, with exploratory assessment of its effects on pain interference and fear of recurrence, of a smartphone-based acceptance and commitment therapy (ACT) intervention to reduce pain interference and fear of recurrence in breast cancer survivors. Methods: This single-center, parallel-group, randomized controlled pirot trial included breast cancer survivors with postmastectomy pain syndrome who were randomly allocated to an ACT intervention group or control group in a 1:1 ratio. Of the 57 patients screened, 45 were randomly assigned to the ACT group (n = 22) and the control group (n = 23). The ACT app offered an 8-week program with outcome measures for before and after the intervention. Primary outcomes were feasibility and adherence, assessed by intervention completion rate, participants’ perceived usefulness, and satisfaction. Secondary outcomes included exploratory clinical measures assessed before and after the intervention. Results: The intervention completion rate for the ACT group was 100%, and the degree to which patients’ needs were met and their overall satisfaction was high (> 60%). One minor adverse event was reported, but the patient had already recovered by the time of the interview stage, and the event was considered minor. No significant improvements were observed in clinical outcomes. Discussion: The results demonstrate the feasibility and acceptability of smartphone-based ACT interventions. Clinical efficacy was not demonstrated and should be evaluated in future trials with adequately powered samples and participants with higher levels of pain interference.
No takes yet. Share an insight, caveat, or question.
Sakai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: